Middleton & Co. Inc. MA Increases Position in STERIS plc (NYSE:STE)

Middleton & Co. Inc. MA increased its holdings in shares of STERIS plc (NYSE:STE) by 0.9% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 49,135 shares of the medical equipment provider’s stock after acquiring an additional 427 shares during the period. STERIS comprises 1.1% of Middleton & Co. Inc. MA’s portfolio, making the stock its 29th biggest position. Middleton & Co. Inc. MA’s holdings in STERIS were worth $10,100,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of STE. Ashton Thomas Securities LLC bought a new stake in STERIS during the 3rd quarter valued at $25,000. Human Investing LLC bought a new stake in shares of STERIS in the fourth quarter valued at about $31,000. Anfield Capital Management LLC lifted its stake in STERIS by 100.0% in the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock worth $37,000 after acquiring an additional 91 shares during the period. Central Pacific Bank Trust Division grew its holdings in STERIS by 65.5% during the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock worth $39,000 after acquiring an additional 76 shares in the last quarter. Finally, Manchester Capital Management LLC increased its position in STERIS by 182.7% during the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock valued at $44,000 after purchasing an additional 137 shares during the period. Institutional investors own 94.69% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the stock. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a research report on Friday, November 8th. Stephens reiterated an “overweight” rating and issued a $240.00 target price on shares of STERIS in a research note on Thursday, February 6th. Piper Sandler increased their price target on shares of STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. Finally, JMP Securities reissued a “market outperform” rating and set a $265.00 target price on shares of STERIS in a research report on Thursday, February 6th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $258.75.

STERIS Stock Down 0.4 %

STERIS stock opened at $219.23 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. STERIS plc has a fifty-two week low of $197.82 and a fifty-two week high of $248.24. The company has a market cap of $21.54 billion, a PE ratio of 46.54 and a beta of 0.84. The business’s 50-day simple moving average is $214.99 and its two-hundred day simple moving average is $223.01.

STERIS (NYSE:STE) last announced its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. Equities analysts anticipate that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Thursday, February 20th will be issued a $0.57 dividend. The ex-dividend date is Thursday, February 20th. This represents a $2.28 annualized dividend and a dividend yield of 1.04%. STERIS’s dividend payout ratio (DPR) is presently 48.41%.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.